Michael Bæk
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Sirtuins and Resveratrol in Medicine 5
-
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Christian A. Olsen (8 shared papers)Carlos Moreno–Yruela (3 shared papers)Alexander L. Nielsen (4 shared papers)Julie E. Bolding (3 shared papers)Daniela Danková (2 shared papers)Lu Yang (1 shared paper)Jiemin Wong (1 shared paper)Yingming Zhao (1 shared paper)
- Journals
- RSC Chemical Biology (1 paper)Chemistry - A European Journal (1 paper)Science Advances (1 paper)Accounts of Chemical Research (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- DenmarkSwitzerlandAustralia
In The Last Decade
Michael Bæk
8 papers receiving 640 citations
Michael Bæk's Hit Papers
Peers
Comparison fields: 5 of 60
- Geriatrics and Gerontology 61
- Cancer Research 185
- Molecular Biology 393
- Physiology 25
- Immunology 66
Countries citing papers authored by Michael Bæk
This map shows the geographic impact of Michael Bæk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bæk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bæk more than expected).
Fields of papers citing papers by Michael Bæk
This network shows the impact of papers produced by Michael Bæk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bæk. The network helps show where Michael Bæk may publish in the future.
Co-authors
The 20 scholars most cited alongside Michael Bæk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Class I histone deacetylases (HDAC1–3) are histone lysine delactylases Hit paper breakdown → | 2022 | 495 |
| 2 | 2022 | 57 | |
| 3 | 2021 | 25 | |
| 4 | 2022 | 25 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 15 | |
| 7 | 2022 | 4 | |
| 8 | 2024 | 3 |
About Michael Bæk
Michael Bæk is a scholar working on Geriatrics and Gerontology, Molecular Biology, Epidemiology, Organic Chemistry and Oncology, having authored 8 papers that have together received 642 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (5 papers), Autophagy in Disease and Therapy (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Click Chemistry and Applications (3 papers), PARP inhibition in cancer therapy (2 papers), Epigenetics and DNA Methylation (1 paper), Adenosine and Purinergic Signaling (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Geriatrics and Gerontology (61 citations), Cancer Research (185 citations), Molecular Biology (393 citations), Physiology (25 citations) and Immunology (66 citations). Michael Bæk has collaborated with scholars based in Denmark, Switzerland and Australia. Frequent co-authors include Christian A. Olsen, Carlos Moreno–Yruela, Alexander L. Nielsen, Julie E. Bolding, Daniela Danková, Lu Yang, Jiemin Wong, Yingming Zhao, Di Zhang and Jinjun Gao. Their work appears in journals such as RSC Chemical Biology, Chemistry - A European Journal, Science Advances, Accounts of Chemical Research and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.